LATEST

• BUSINESS Janssen Files TAR-200 in Japan for High-Risk Bladder Cancer
  September 9, 2025

• BUSINESS Amicus CEO Confident on US$1 Billion Sales Target as Japan Pompe Launch Gets Underway
  September 9, 2025

• BUSINESS GSK Recalls 7 Lots of Omjjara in Japan over Quality Issue
  September 9, 2025

• BUSINESS Takeda Nabs Label Expansion for VWD Drug Vonvendi in US
  September 9, 2025

• REGULATORY Japan Panel Approves 5 COVID Vaccines for NIP Use from October
  September 9, 2025

• BUSINESS Talvey Seen as Promising Option for Hard-to-Treat Multiple Myeloma: Oncologist
  September 8, 2025

• BUSINESS KM Biologics Developing Higher-Yield Liquid Immunoglobulin to Boost Efficiency and Supply
  September 8, 2025

• ORGANIZATION JPMA Code & Compliance Chair Stresses Need to Embed Spirit of Revised COP
  September 8, 2025

• REGULATORY MHLW Seeks to Raise Quality of Prefectural Generic GMP Inspections
  September 8, 2025

• BUSINESS Susmed Wins Partial Change Approval for Insomnia App, Seeks Coverage
  September 8, 2025

• BUSINESS Ferring Files for Japan Approval of Bladder Cancer Gene Therapy
  September 8, 2025

• COMMENTARY MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
  September 8, 2025

• BUSINESS Kaken’s Onychomycosis Drug Grabs German Approval
  September 8, 2025

• BUSINESS Japan Ethical Drug Sales Inch Up 0.7% in July: Crecon
  September 8, 2025

• REGULATORY Novartis’ Radioligand Therapy, More Meds Inch Closer to Japan Approval with Panel OK
  August 25, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18